Literature DB >> 814821

Cholecystokinin-decreased food intake in rhesus monkeys.

J Gibbs, J D Falasco, P R McHugh.   

Abstract

Five rhesus monkeys were infused intravenously with partially purified cholecystokinin (CCK) Just prior to a test meal of solid food after overnight food deprivation; CCK produced large, rapid, dose related suppressions of feeding. The lowest dose tested (5 Ivy U/kg body wt) produced a significant inhibition of food intake (26% suppression, P less than 0.05). Equivalent infusions of partially purified CCK or the synthetic COOH-terminal octapeptide of CCK (a pure fragment with all the biological activity of the full molecule) produced equivalent suppressions. In a second experiment, gastric preloads of a potent releaser of endogenous CCK, L-phenylalanine (L-Phe), and a weak releaser, D-phenylalanine (D-Phe) were compared for their relative abilities to suppress food intake at a test meal in nine rhesus monkeys after overnight deprivation. L-Phenylalanine produced large, rapid, dose-related suppressions of feeding, but D-Phe did not. The threshold dose of L-Phe was 0.5 g/kg (32% suppression, P less than 0.01). Neither CCK nor L-Phe caused signs of illness in these experiments. The results demonstrate that intravenous exogenous CCK suppresses feeding in rhesus monkeys and suggest that endogenous CCK has the same effect; they are consistent with the hypothesis that CCK is a satiety signal.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 814821     DOI: 10.1152/ajplegacy.1976.230.1.15

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  25 in total

Review 1.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

2.  Amino acids stimulate cholecystokinin release through the Ca2+-sensing receptor.

Authors:  Yu Wang; Rashmi Chandra; Leigh Ann Samsa; Barry Gooch; Brian E Fee; J Michael Cook; Steven R Vigna; Augustus O Grant; Rodger A Liddle
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-23       Impact factor: 4.052

Review 3.  Melanocortin neurons: Multiple routes to regulation of metabolism.

Authors:  Wen-Jie Shen; Ting Yao; Xingxing Kong; Kevin W Williams; Tiemin Liu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-09       Impact factor: 5.187

4.  TMEM16B determines cholecystokinin sensitivity of intestinal vagal afferents of nodose neurons.

Authors:  Runping Wang; Yongjun Lu; Michael Z Cicha; Madhu V Singh; Christopher J Benson; Christopher J Madden; Mark W Chapleau; François M Abboud
Journal:  JCI Insight       Date:  2019-03-07

Review 5.  Satietin; a 50,000 dalton glycoprotein in human serum with potent, long-lasting and selective anorectic activity.

Authors:  J Knoll
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

6.  Satietin, a blood-borne anorectic glycoprotein, as the putative rate-limiting satiety signal in the negative feed-back of food intake.

Authors:  J Knoll
Journal:  Z Ernahrungswiss       Date:  1984-06

Review 7.  Upper intestinal lipids regulate energy and glucose homeostasis.

Authors:  Grace W C Cheung; Andrea Kokorovic; Tony K T Lam
Journal:  Cell Mol Life Sci       Date:  2009-06-10       Impact factor: 9.261

8.  Peptides and the control of meal size.

Authors:  S C Woods; D B West; Leslie J Stein; L D McKay; Elizabeth C Lotter; Stephanie G Porte; Nancy J Kenney; D Porte
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

9.  Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY.

Authors:  Brenna M Flannery; Erica S Clark; James J Pestka
Journal:  Toxicol Sci       Date:  2012-08-17       Impact factor: 4.849

10.  Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats.

Authors:  Chiu-Lung Wu; Chen-Road Hung; Full-Young Chang; K-Y Francis Pau; Paulus S Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-26       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.